- Home
- TPST vs MNDO Comparison
TPST vs MNDO Comparison
Compare TPST & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- MNDO
- Stock Information
- Founded
- TPST 2011
- MNDO 1995
- Country
- TPST United States
- MNDO Israel
- Employees
- TPST N/A
- MNDO N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- MNDO EDP Services
- Sector
- TPST Health Care
- MNDO Technology
- Exchange
- TPST Nasdaq
- MNDO Nasdaq
- Market Cap
- TPST 33.0M
- MNDO 34.2M
- IPO Year
- TPST N/A
- MNDO 2000
- Fundamental
- Price
- TPST $6.86
- MNDO $1.34
- Analyst Decision
- TPST Hold
- MNDO
- Analyst Count
- TPST 3
- MNDO 0
- Target Price
- TPST $30.00
- MNDO N/A
- AVG Volume (30 Days)
- TPST 247.2K
- MNDO 40.6K
- Earning Date
- TPST 08-07-2025
- MNDO 08-05-2025
- Dividend Yield
- TPST N/A
- MNDO 16.06%
- EPS Growth
- TPST N/A
- MNDO N/A
- EPS
- TPST N/A
- MNDO 0.17
- Revenue
- TPST N/A
- MNDO $20,677,000.00
- Revenue This Year
- TPST N/A
- MNDO N/A
- Revenue Next Year
- TPST N/A
- MNDO N/A
- P/E Ratio
- TPST N/A
- MNDO $7.79
- Revenue Growth
- TPST N/A
- MNDO N/A
- 52 Week Low
- TPST $5.35
- MNDO $1.31
- 52 Week High
- TPST $30.03
- MNDO $2.13
- Technical
- Relative Strength Index (RSI)
- TPST 49.91
- MNDO 30.99
- Support Level
- TPST $6.87
- MNDO $1.33
- Resistance Level
- TPST $7.25
- MNDO $1.37
- Average True Range (ATR)
- TPST 0.67
- MNDO 0.03
- MACD
- TPST -0.02
- MNDO -0.00
- Stochastic Oscillator
- TPST 11.20
- MNDO 11.11
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About MNDO MIND C.T.I. Ltd.
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.